Noramco
Noramco
Noramco
  • About Us
    • About Noramco
    • Our People
    • Leadership
    • Excellence in Compliance
    • Minimizing Risk
  • Products & Solutions
    • Active Pharmaceutical Ingredients
      • Active Pharmaceutical Ingredients
      • Nal Family of Antagonists
      • ADHD / Stimulants
      • Full Product List
    • Noramco Solutions
      • Noramco Solutions
      • Clinical Supply
      • Controlled Substance Building Blocks and Intermediates
    • Platform Technologies
      • Platform Technologies
      • Platform Technology: Custom Synthesis
    • Reference Standards
      • Reference Standards
      • Reference Standards: Custom Synthesis
    • Reference Standards Store
  • Careers
  • News & Events
    • News & Events
    • Press Releases
  • Contact

Sort by

  • Default sorting
  • Sort by popularity
  • Sort by newness
  • Sort by price: low to high
  • Sort by price: high to low

View

  • 9 items
  • 15 items
  • 30 items

Showing 1–9 of 17 results

  • 13_15,16-Dehydrobuprenorphine-Base
    Quick ViewSelect options

    15,16-Dehydrobuprenorphine Base (CII)

    $863.00 – $3,452.00
    <span style="color: #000000;"><strong>CAS#</strong></span> 61577-04-6 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-1052-**
    Quick ViewSelect options
  • 14_17,18-Dehydrobuprenorphine-Base
    Quick ViewSelect options

    17,18-Dehydrobuprenorphine Base (CII)

    $863.00 – $3,452.00
    <span style="color: #000000;"><strong>OTHER NAMES:</strong></span> EP Impurity J <span style="color: #000000;"><strong>CAS#</strong></span> 155203-05-7 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-1036-**
    Quick ViewSelect options
  • 15_19,19-Ethenylbuprenorphine
    Quick ViewSelect options

    19,19’ Ethenylbuprenorphine (CII)

    $1,740.00 – $6,960.00
    <span style="color: #000000;"><strong>OTHER NAMES:</strong></span> EP Impurity F <strong><span style="color: #000000;">CAS#</span></strong>  97203-04-8 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-2164-**
    Quick ViewSelect options
  • 16_2,2-Bisbuprenorphine-Base
    Quick ViewSelect options

    2,2′-Bisbuprenorphine Base (CII)

    $1,438.00 – $5,752.00
    EP Impurity G CAS #163597-04-4 NDC #51634-2119-**
    Quick ViewSelect options
  • 17_3-Deshydroxybuprenorphine-Base
    Quick ViewSelect options

    3-Deshydroxybuprenorphine Base (CII)

    $863.00 – $3,452.00
    <span style="color: #000000;"><strong>NDC#</strong></span> 51634-1037-**
    Quick ViewSelect options
  • 19_3-O-Methyl-N-cyanonorbuprenorphine-Base
    Quick ViewSelect options

    3-O-Methyl-N-cyanonorbuprenorphine Base (CII)

    $863.00 – $3,452.00
    EP Impurity C CAS #16614-60-1 NDC #51634-1041-**
    Quick ViewSelect options
  • ref-standards-vial-temp
    Quick ViewSelect options

    3-O-Methyl-N-methylnorbuprenorphine Base (CII)

    $863.00 – $3,452.00
    CAS #16196-70-6 NDC #51634-1042-**
    Quick ViewSelect options
  • 21_3-O-Methylnorbuprenorphine-Base
    Quick ViewSelect options

    3-O-Methylnorbuprenorphine Base (CII)

    $863.00 – $3,452.00
    CAS #16614-59-8 NDC #51634-1043-**
    Quick ViewSelect options
  • 22_6-O-Desmethylbuprenorphine-Base
    Quick ViewSelect options

    6-O-Desmethylbuprenorphine Base (CII)

    $863.00 – $3,452.00
    EP Impurity E CAS #130668-48-3 NDC #51634-1038-**
    Quick ViewSelect options
  • 1
  • 2

Recent Articles

  • Noramco CEO Lee Karras discusses $25 million Halo investment with PharmTech
  • Diversifying the Supply of Raw Materials
  • Noramco Announces Strategic Alignment with Purisys and Halo Pharma, Launching the Noramco Group as an Integrated North American-Based API and Drug Product Supply Chain Services Provider
  • Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit
  • Noramco Announces Submission and Reactivation of the Drug Master File for Active Pharmaceutical Ingredient Methylnaltrexone Bromide
Copyright 2025 Noramco. All Rights Reserved. Contact | Legal Notice | Privacy Policy | Terms & Conditions | Benefits Transparency Mandate